Target is still at a hefty discount, some significant de-risking would occur post CHM being extinguished.There is a real opportunity in the next two quarters for a kick along. Best wishes to all who invest.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%